Back

Medicure completes enrollment in MEND-PNPO Phase 3 trial

Verifying
  • Medicure completed enrollment in the MEND-PNPO Phase 3 clinical trial.
  • MEND-PNPO was identified as a Phase 3 clinical trial.
  • MCUJF was identified as the stock-news symbol for Medicure.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Medicure completes enrollment in MEND-PNPO Phase 3 trial - CoinPost Terminal